Trimethylamine N-oxide (TMAO) is a biologically active molecule and is a putative promoter
of chronic diseases including atherosclerosis in humans. Host intestinal bacteria produce its …

BACKGROUND Nutritional metabolomics is rapidly evolving to integrate nutrition with
complex metabolomics data to discover new biomarkers of nutritional exposure and status …

Aims The microbiome-derived metabolite trimethylamine-N-oxide (TMAO) has attracted
major interest and controversy both as a diagnostic biomarker and therapeutic target in …

Production of trimethylamine-N-oxide (TMAO), a biomarker of CVD risk, is dependent on
intestinal microbiota, but little is known of dietary conditions promoting changes in gut …

We critically review potential involvement of trimethylamine N-oxide (TMAO) as a link
between diet, the gut microbiota and CVD. Generated primarily from dietary choline and …

Emerging evidence has linked the gut microbiome changes to schizophrenia. However,
there has been limited research into the functional pathways by which the gut microbiota …

Background: Clinical nutrition research often lacks robust markers of compliance,
complicating the interpretation of clinical trials and observational studies of free-living …

Chronic kidney disease (CKD) has been associated with changes in gut microbial ecology,
or “dysbiosis,” which may contribute to disease progression. Recent studies have focused …

Chronic obstructive pulmonary disease (COPD) comprises multiple phenotypes such as
airflow obstruction, emphysema, and frequent episodes of acute worsening of respiratory …

Abstract Purpose of Review The aim of the review was to evaluate which diets are
associated with higher TMAO levels. Recent Findings Several studies have shown that …